{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:36:59Z","timestamp":1792103819158,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS075487"],"award-info":[{"award-number":["R01NS075487"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AG032438"],"award-info":[{"award-number":["U19AG032438"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U-01-AG042791"],"award-info":[{"award-number":["U-01-AG042791"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U19 AG032438"],"award-info":[{"award-number":["U19 AG032438"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.neurobiolaging.2016.09.020","type":"journal-article","created":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T09:10:18Z","timestamp":1475831418000},"page":"216.e7-216.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Clinical, imaging, pathological, and biochemical characterization of a novel presenilin 1 mutation (N135Y) causing Alzheimer's disease"],"prefix":"10.1016","volume":"49","author":[{"given":"Marissa","family":"Natelson Love","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9852-5504","authenticated-orcid":false,"given":"J. Nicholas","family":"Cochran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle A.","family":"Den Beste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Geldmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8114-0552","authenticated-orcid":false,"given":"Tammie L.","family":"Benzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2109-2955","authenticated-orcid":false,"given":"Brian A.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall J.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1810-9763","authenticated-orcid":false,"given":"Erik D.","family":"Roberson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A\u00a0method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib3","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1038\/emboj.2012.79","article-title":"The mechanism of \u03b3-Secretase dysfunction in familial Alzheimer disease","volume":"31","author":"Ch\u00e1vez-Guti\u00e9rrez","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib4","doi-asserted-by":"crossref","first-page":"e46688","DOI":"10.1371\/journal.pone.0046688","article-title":"Predicting the functional effect of amino acid substitutions and indels","volume":"7","author":"Choi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ana.410420121","article-title":"Early-onset Alzheimer's disease with a presenilin-1 mutation at the site corresponding to the Volga German presenilin-2 mutation","volume":"42","author":"Crook","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0896-6273(03)00205-8","article-title":"Aph-1, Pen-2, and nicastrin with presenilin generate an active gamma-secretase complex","volume":"38","author":"De Strooper","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.embor.7400897","article-title":"Loss-of-function presenilin mutations in Alzheimer disease. Talking point on the role of presenilin mutations in Alzheimer disease","volume":"8","author":"De Strooper","year":"2007","journal-title":"EMBO Rep."},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib8","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","article-title":"An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest","volume":"31","author":"Desikan","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib9","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/383710a0","article-title":"Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1","volume":"383","author":"Duff","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/syn.21566","article-title":"Characterization of extrastriatal D2 in\u00a0vivo specific binding of [(1)(8)F](N-methyl)benperidol using PET","volume":"66","author":"Eisenstein","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib11","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","article-title":"FreeSurfer","volume":"62","author":"Fischl","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","article-title":"Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain","volume":"33","author":"Fischl","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib13","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.neurobiolaging.2008.06.012","article-title":"Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP","volume":"31","author":"Guerreiro","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0304-3940(01)01910-3","article-title":"Presenilin mutations line up along transmembrane alpha-helices","volume":"306","author":"Hardy","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib15","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jalz.2010.03.004","article-title":"Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative","volume":"6","author":"Jack","year":"2010","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jmri.21049","article-title":"The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods","volume":"27","author":"Jack","year":"2008","journal-title":"J.\u00a0Magn. Reson. Imaging"},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.2892","article-title":"A\u00a0general framework for estimating the relative pathogenicity of human genetic variants","volume":"46","author":"Kircher","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib18","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.2353\/ajpath.2006.051232","article-title":"Genetically augmenting A\u03b242 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice","volume":"168","author":"Kitazawa","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib19","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/humu.20336","article-title":"Mean age-of-onset of familial Alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40","volume":"27","author":"Kumar-Singh","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib20","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/mp.2015.131","article-title":"Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's disease","volume":"20","author":"Lalli","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib21","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.7638622","article-title":"Candidate gene for the chromosome 1 familial Alzheimer\u2019s disease locus","volume":"269","author":"Levy-Lahad","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib22","series-title":"The Behavioral Neurology of Dementia","author":"Miller","year":"2009"},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/archneurol.2009.15","article-title":"Epilepsy and cognitive impairments in Alzheimer disease","volume":"66","author":"Palop","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib25","first-page":"904","article-title":"Correction for partial volume effects in PET: principle and validation","volume":"39","author":"Rousset","year":"1998","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib26","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.nucmedbio.2005.05.002","article-title":"Registration of [18F]FDG microPET and small-animal MRI","volume":"32","author":"Rowland","year":"2005","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/WAD.0b013e3181732399","article-title":"Early onset familial Alzheimer Disease with spastic paraparesis, dysarthria, and seizures and N135S mutation in PSEN1","volume":"22","author":"Rudzinski","year":"2008","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/WNL.0000000000000596","article-title":"Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis","volume":"83","author":"Ryman","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib29","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in\u00a0vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease","volume":"2","author":"Scheuner","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jfma.2015.08.004","article-title":"A\u00a0systematic review of familial Alzheimer's disease: differences in presentation of clinical features among three mutated genes and potential ethnic differences","volume":"115","author":"Shea","year":"2015","journal-title":"J.\u00a0Formos. Med. Assoc."},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib31","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuroimage.2014.11.058","article-title":"Partial volume correction in quantitative amyloid imaging","volume":"107","author":"Su","year":"2015","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib33","doi-asserted-by":"crossref","first-page":"e73377","DOI":"10.1371\/journal.pone.0073377","article-title":"Quantitative analysis of PiB-PET with FreeSurfer ROIs","volume":"8","author":"Su","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib34","unstructured":"Tang, M., Ryman, D.C., McDade, E., Jasielec, M.S., Buckles, V.D., Cairns, N.J., Fagan, A.M., Goate, A., Marcus, D.S., Xiong, C., Allegri, R.F., Chhatwal, J.P., Danek, A., Farlow, M.R., Fox, N., Ghetti, B., Graff-Radford, N.R., Laske, C., Martins, R.N., Masters, C.L., Mayeux, R.P., Ringman, J.M., Rossor, M.N., Salloway, S.P., Schofield, P.R., Morris, J.C., Bateman, R.J., and the Dominantly Inherited Alzheimer Network. Neurological manifestations of autosomal dominant Alzheimer's disease from the DIAN cohort and a meta-analysis. (In press). Lancet Neurology."},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib35","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.410300503","article-title":"Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study","volume":"30","author":"Vonsattel","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib36","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1042\/BST0331087","article-title":"The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention","volume":"33","author":"Walsh","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neurobiolaging.2016.09.020_bib37","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.neuron.2015.02.010","article-title":"Presenilin-1 knockin mice reveal loss-of-function mechanism for familial Alzheimer's disease","volume":"85","author":"Xia","year":"2015","journal-title":"Neuron"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458016302342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458016302342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T11:32:50Z","timestamp":1582543970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458016302342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":37,"alternative-id":["S0197458016302342"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.09.020","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical, imaging, pathological, and biochemical characterization of a novel presenilin 1 mutation (N135Y) causing Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}